Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UCLA Researchers Discover New Method to generate human bone

25.04.2005


Protein Found by UCLA Shows Generation of New Bone in Patients Who Lack It, as Well as Faster, More Reliable Healing of Fractures

By studying diseases in which the human body generates too much bone, UCLA researchers have discovered and isolated a natural molecule that can be used to heal fractures and generate new bone growth in patients who lack it.

Bioengineering Professor Ben Wu at UCLA’s Henry Samueli School of Engineering and Applied Science, and Thomas R. Bales Professor Kang Ting at UCLA’s School of Dentistry are developing a new molecule they’ve named UCB, or University of California Bone.



The core technology developed by Wu and Ting is potentially the most significant advancement in bone regeneration since the discovery of bone morphogenetic proteins (BMPs) by Dr. Marshall Urist at UCLA in the 1960s.

“For the average person, this new development potentially means faster, more reliable bone healing with fewer side effects at a lower cost,” says Ting. “In more severe cases, such as in children born with congenital anomalies, the new protein may offer an advanced solution to repair cleft palates, which involves bone deficiencies, and also aid in repairing other bone defects such as fractures, spinal fusion and implant integration.”

UCB differs significantly from BMPs, the protein currently used by orthopedic surgeons to aid in bone repair, in that UCB has potentially fewer side effects. With BMPs, bone formation has been observed to occur at locations outside of the intended implant site, and tissue other than bone also has been reported. In contrast, UCB’s main effects appear to be more specific towards bone formation process, giving surgeons increased control over where bone forms. Says Wu, UCB is more specific because it works downstream from the body’s “master switch” for bone formation. Because the two molecules act on different targets, UCB also works synergistically with BMPs to form more bone than is typically possible with BMPs alone.

The key to success for these proteins is designing the right carrier – using the protein alone is not effective. Currently BMPs are delivered with a collagen-sponge into the area where bone growth is needed. The sponge offers little biological benefits for the surgeon, and proteins can migrate away from the sponge. In contrast, the team at UCLA is developing a carrier that is engineered for UCB activities in the biological environment.

“It’s the right combination of carrier and protein that further increases the stability and activity of UCB. For certain clinical applications, we will need to develop injectable options that are minimally invasive. For other clinical applications, we will need moldable carriers that can hold the UCB in place better. By making life easier for the surgeons, they can focus on the surgery. Ultimately, the patient benefits,” says Ting.

Another current option is to use the patient’s own bone grafted from another part of the body.

“Right now we are doing a lot of spinal fusions and these fusions require us to have bone graft material. The problem with taking a patient’s own bone for this procedure is that aside from the pain, which often becomes severe and persistent, there is a high risk of infection. This adds higher risk to the surgery,” says Dr. Jeffrey Wang, Chief of Orthopaedic Spine Service at the UCLA Comprehensive Spine Center. “The discovery of UCB could potentially be a better way to do spinal fusion. Used in conjunction with cartilage growth, this discovery may completely change the way we look at things in the future,” added Wang.

BMPs, found in demineralized bone, were discovered in the 1960s, but until the advent of biotechnology, the arduous process and high cost associated with making BMPs from animal-derived bone was deemed too difficult. To date, only two companies have received FDA approval for BMPs, making the product cost high, and the treatment prohibitive for many.

Ting, who works frequently with children who have congenital anomalies, began his bone research eight years ago. Wu joined him three years ago, and their collaboration resulted in the recent discovery.

“I thought it was important to understand how accelerated bone growth in one situation might be applied to situations where more bone growth could accelerate healing in those patients who lacked normal or necessary bone formation,” says Ting. “This discovery will provide another option for patients. Competition will make treatment options safer, less expensive, and more accessible for those families who really need it.”

The team of UCLA researchers, under the business name Bone Biologics, already has begun forming partnerships that may assist in the development of appropriate carriers for UCB. The Musculoskeletal Transplant Foundation (MTF), the nation’s largest tissue bank, has signed a collaborative development agreement with Wu and Ting to provide customized tissue forms to support the delivery of UCB.

“We are excited by the initial work of Dr.’s Wu and Ting,” stated MTF President and CEO, Bruce Stroever. The development of new protein sources tied to an appropriate carrier that encourage new bone formation and speed healing is work that is synergistic to MTF’s mission of advancing the science of bone, ligament, cartilage and skin transplantation. We are pleased to be working with UCLA.”

Wu and Ting anticipate FDA approval and first sales of the product in the next seven to nine years. Other collaborators on this technology include Dr. Xinli Zhang and Dr. Chia Soo at UCLA, and Dr. Shunichi Kuroda at Osaka University. The new technology recently has been awarded the prestigious 2005 Hatton Award from the International Association of Dental Research.

For more information, media should contact Melissa Abraham (mabraham@support.ucla.edu or 310.206.0540.)

Melissa Abraham | EurekAlert!
Further information:
http://www.ucla.edu

More articles from Life Sciences:

nachricht Making fuel out of thick air
08.12.2017 | DOE/Argonne National Laboratory

nachricht ‘Spying’ on the hidden geometry of complex networks through machine intelligence
08.12.2017 | Technische Universität Dresden

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

Im Focus: Successful Mechanical Testing of Nanowires

With innovative experiments, researchers at the Helmholtz-Zentrums Geesthacht and the Technical University Hamburg unravel why tiny metallic structures are extremely strong

Light-weight and simultaneously strong – porous metallic nanomaterials promise interesting applications as, for instance, for future aeroplanes with enhanced...

Im Focus: Virtual Reality for Bacteria

An interdisciplinary group of researchers interfaced individual bacteria with a computer to build a hybrid bio-digital circuit - Study published in Nature Communications

Scientists at the Institute of Science and Technology Austria (IST Austria) have managed to control the behavior of individual bacteria by connecting them to a...

Im Focus: A space-time sensor for light-matter interactions

Physicists in the Laboratory for Attosecond Physics (run jointly by LMU Munich and the Max Planck Institute for Quantum Optics) have developed an attosecond electron microscope that allows them to visualize the dispersion of light in time and space, and observe the motions of electrons in atoms.

The most basic of all physical interactions in nature is that between light and matter. This interaction takes place in attosecond times (i.e. billionths of a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

Midwife and signpost for photons

11.12.2017 | Physics and Astronomy

How do megacities impact coastal seas? Searching for evidence in Chinese marginal seas

11.12.2017 | Earth Sciences

PhoxTroT: Optical Interconnect Technologies Revolutionized Data Centers and HPC Systems

11.12.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>